The state of the fight:
- Gavi inked a 550-million-dose supply deal with China’s CNBG and Sinovac.
- Bharat Biotech applied for WHO Emergency Use Listing of its inactivated vaccine.
- Cuba authorized BioFarmaCuba’s Abdala vaccine.
Approved or authorized vaccines
The U.S. FDA granted Priority Review to Pfizer/BioNTech’s Comirnaty vaccine in the companies’ bid for full…